קפסיטבין אינובמד 500 מג ישראל - עברית - Ministry of Health

קפסיטבין אינובמד 500 מג

inovamed ltd - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine

קפסיטבין אינובמד 500 מג ישראל - עברית - Ministry of Health

קפסיטבין אינובמד 500 מג

inovamed ltd - capecitabine - טבליות מצופות פילם - capecitabine 500 mg - capecitabine

רפאסאל 500 מג קפליות ישראל - עברית - Ministry of Health

רפאסאל 500 מג קפליות

rafa laboratories ltd - mesalazine - caplets - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

רפאסאל 500 מג פתילות ישראל - עברית - Ministry of Health

רפאסאל 500 מג פתילות

rafa laboratories ltd - mesalazine - פתילות - mesalazine 500 mg - mesalazine - mesalazine - treatment and prevention of ulcerative colitis and crohn's disease.

פנטסה טבליות בשחרור איטי 500 מג ישראל - עברית - Ministry of Health

פנטסה טבליות בשחרור איטי 500 מג

ferring pharmaceuticals ltd - mesalazine - טבליות בשחרור איטי - mesalazine 500 mg - mesalazine - mesalazine - ulcerative colitis. crohn's disease.

ג'נואט 50/500 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/500 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 500 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50/500 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/500 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 500 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

ג'נואט 50/500 מ"ג טבליות ישראל - עברית - Ministry of Health

ג'נואט 50/500 מ"ג טבליות

merck sharp & dohme israel ltd - metformin hydrochloride 500 mg; sitagliptin as monohydrate phosphate 50 mg - tablets - metformin - januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. important limitations of use:januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.januet has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using januet.

נובוגרד 1 מ"ג/500 מ"ג ישראל - עברית - Ministry of Health

נובוגרד 1 מ"ג/500 מ"ג

novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 1 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.

נובוגרד 2 מ"ג/500 מ"ג ישראל - עברית - Ministry of Health

נובוגרד 2 מ"ג/500 מ"ג

novo nordisk ltd - metformin hydrochloride 500 mg; repaglinide 2 mg - tablets - metformin - novogard is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 mellitus who are already treated with a meglitinide and metformin hcl or who have inadequate glycemic control on a meglitinide alone or metformin hcl alone.